Soldat-Stankovid et al. observed a decrease in AMH levels in normal-weight patients with PCOS (BMI ≤ 25 kg/m2) treated with MET (1500 mg/d) for 6 months [51]. The gene discussed is AMH; the disease is polycystic ovary syndrome.